A bill to require the Secretary of Health and Human Services to make determinations of the exclusivity periods for which licensed biological products are eligible.

Summary

No official summary available for this bill.

Full Text

Legislative Actions

1. 2026-04-16

   Introduced in Senate

2. 2026-04-16

   Read twice and referred to the Committee on Health, Education, Labor, and Pensions.